Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+30.4%
5Y CAGR+4.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+30.4%/yr
vs -1.6%/yr prior
5Y CAGR
+4.4%/yr
Recent acceleration
Acceleration
+32.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$134.67M+5.7%
2024$127.37M+38.2%
2023$92.17M+51.7%
2022$60.76M-17.6%
2021$73.79M-32.2%
2020$108.75M-9.2%
2019$119.73M+84.5%
2018$64.91M+4.2%
2017$62.26M+47.4%
2016$42.25M-